{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:37:36Z","timestamp":1792993056080,"version":"4.5.0"},"reference-count":67,"publisher":"Bentham Science Publishers Ltd.","issue":"30","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The tryptophan (TRP)-serotonin pathway is disrupted and redirected towards kynurenine by the action of indoleamine 2,3-dioxygenase 2 (IDO2) and kynureninase\n(KYNU). In ovarian cancer, concurrent kynurenine activation encourages tumor growth and immune evasion. The investigation of phytochemicals has focused on identifying therapeutic targets in ovarian cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Gene expression, survival plots, and comparisons of correlated genes were computed\nto obtain holistic insights into the identified targets. A Kaplan-Meier analysis was performed to\nexamine the survival patterns of IDO1 and KYNU targets. Molecular docking was performed to\ndetermine the binding affinity of ligands, and the Desmond module of Schrodinger was used to\nconfirm the docking scores through simulation. Physiochemical and ADMET properties were assessed using SwissADME and pkCSM. Electronic effects and stability were further confirmed\nusing Gaussian software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Protein-protein interactions of TRP metabolism revealed IDO2 and KYNU as potential\ntargets involved in pathway diversion. The comparison of mutated and non-mutated targets\nshowed no significant difference, reflecting the tumor\u2019s heterogeneity and the limited number of\nmutated samples. Molecular docking studies of 368 phytochemicals from six sources, reported\nto have anti-ovarian cancer properties, revealed 11 phytochemicals with higher binding affinities of -9.7 kcal\/mol for IDO2 and -9.4 kcal\/mol for KYNU. The interaction between the target\nand ligand was confirmed by molecular dynamics simulation using the Desmond module V3 of\nSchr\u00f6dinger software. The stability and reactivity of phytochemicals were assessed using HOMO-LUMO and energy gap calculations. The highest electron stability was shown in 24MC\n(6.95 eV) and C24\u03b2 (6.93 eV) compared with controls. The identified phytochemicals were further evaluated for their ADMET properties to refine therapeutic hit compounds. Compounds,\nsuch as Hemanthidine (HAT), Ergometrine (ERG), Tazettine (TZT), Tenatoprazole (TU-199),\nRucaparib (CO-338), and Nicotinylalanine (NAL), have been reported to improve drug absorption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>By altering the ovarian cancer microenvironment, targeting immunometabolism\nwith a clinically relevant approach improves therapeutic efficacy. Target expression clarifies the\nimmune-rich tumor microenvironment rather than the actual tumor growth. Higher-binding-\naffinity compounds demonstrate high electronic stability in energy estimates as well as improved\ndrug availability in pharmacokinetic investigations. However, this finding remains a\ncomputational approach and requires experimental validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>By altering the ovarian cancer microenvironment, targeting immunometabolism\nwith a clinically relevant approach improves therapeutic efficacy. Target expression clarifies the\nimmune-rich tumor microenvironment rather than the actual tumor growth. Higher-binding-affinity compounds demonstrate high electronic stability in energy estimates as well as improved drug availability in pharmacokinetic investigations. However, this finding remains a\ncomputational approach and requires experimental validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This computational study identifies suitable hit compounds for targeting TRP depletion, expanding the scope for subsequent in vitro and in vivo exploration to expedite drug discovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673450210260701040244","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T17:17:53Z","timestamp":1788110273000},"page":"6435-6465","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological Modulation of the Tryptophan-kynurenine Pathway by the Intervention of Indoleamine 2,3-dioxygenase 2 (IDO2) and Kynureninase (KYNU) in Ovarian Cancer"],"prefix":"10.2174","volume":"33","author":[{"given":"Pavithra","family":"Velmurugan","sequence":"first","affiliation":[{"name":"Mahatma Gandhi Medical Advanced Research Institute, Sri Balaji Vidyapeeth University (Deemed-to-be-University), Pondicherry, 607402, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8973-3507","authenticated-orcid":true,"given":"Rajesh","family":"Parsanathan","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Integrative Biology, Central University of Tamil Nadu, Neelakudi, Thiruvarur, 610005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7554-633X","authenticated-orcid":true,"given":"Gopalakrishnan","family":"Shankari","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics, Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, 641021, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7359-0986","authenticated-orcid":true,"given":"Haema","family":"Ganapathi","sequence":"additional","affiliation":[{"name":"School ofPharmacy, Sri Balaji Vidyapeeth University (Deemed- to be-University), Pondicherry, 607402, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1140-883X","authenticated-orcid":true,"given":"Balasubramanian","family":"Moovarkumudalvan","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi Medical Advanced Research Institute, Sri Balaji Vidyapeeth University (Deemed-to-be-University), Pondicherry, 607402, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9998-020X","authenticated-orcid":true,"given":"Abhimanyu K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi Medical Advanced Research Institute, Sri Balaji Vidyapeeth University (Deemed-to-be-University), Pondicherry, 607402, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-3058","authenticated-orcid":true,"given":"Suresh Kumar","family":"Saravanan","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi Medical Advanced Research Institute, Sri Balaji Vidyapeeth University (Deemed-to-be-University), Pondicherry, 607402, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-3382","authenticated-orcid":true,"given":"Sundararaj","family":"Rajamanikandan","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics, Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, 641021, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7379-4735","authenticated-orcid":true,"given":"Veni","family":"Subramanyam","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi Medical Advanced Research Institute, Sri Balaji Vidyapeeth University (Deemed-to-be-University), Pondicherry, 607402, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.3390\/ijms26104611","volume":"26","author":"Smolarz B.","year":"2025","unstructured":"Smolarz B.; Biernacka K.; \u0141ukasiewicz H.; Samulak D.; Piekarska E.; Romanowicz H.; Makowska M.; Ovarian Cancer \u2014 Epidemiology, classification, pathogenesis, treatment, and estrogen receptors\u2019 molecular backgrounds. Int J Mol Sci  2025,26(10),4611","journal-title":"Int J Mol Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12920-024-01917-4","volume":"17","author":"Tang L.","year":"2024","unstructured":"Tang L.; Ye H.; Chen L.; Dong W.; Hu X.; Yu L..; Tumorigenic role of Pak4 in ovarian cancer and its correlation with immune infiltration. BMC Med Genomics  2024,17(1),148","journal-title":"BMC Med Genomics"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1142\/S2737416525500759","volume":"25","author":"Velmurugan P.","year":"2026","unstructured":"Velmurugan P.; Shankari G.; Ganapathi H.; Moovarkumudalvan B.; Saravanan SK.; Kumar V.; Rajamanikandan S.; Subramanyam V.; Harnessing phytochemistry to combat indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2 in restoring tryptophan homeostasis in ovarian cancer. J Comput Biophys Chem  2026,25(06),919-944","journal-title":"J Comput Biophys Chem"},{"key":"ref=4","unstructured":"Cancer Stat Facts: Ovarian Cancer.  Available from:  https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"8776","DOI":"10.3390\/ijms21228776","volume":"21","author":"Barik S.","year":"2020","unstructured":"Barik S.; The uniqueness of tryptophan in biology: Properties, metabolism, interactions and localization in proteins. Int J Mol Sci  2020,21(22),8776","journal-title":"Int J Mol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1524651","DOI":"10.3389\/fonc.2024.1524651","volume":"14","author":"Kang I.","year":"2025","unstructured":"Kang I.; Theodoropoulos G.; Wangpaichitr M.; Targeting the kynurenine pathway: Another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells. Front Oncol  2025,14(1524651),1524651","journal-title":"Front Oncol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.crimmu.2021.08.002","volume":"2","author":"Sarkar T.","year":"2021","unstructured":"Sarkar T.; Dhar S.; Sa G.; Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape. Curr Res Immunol  2021,2,132-141","journal-title":"Curr Res Immunol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"e1238","DOI":"10.1002\/cti2.1238","volume":"10","author":"Riggan L.","year":"2021","unstructured":"Riggan L.; Shah S.; O'Sullivan T.E.; Arrested development: Suppression of NK cell function in the tumor microenvironment. Clin Transl Immunol  2021,10(1),e1238","journal-title":"Clin Transl Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"18691","DOI":"10.1002\/cam4.6484","volume":"12","author":"Basson C.","year":"2023","unstructured":"Basson C.; Serem J.C.; Hlophe Y.N.; Bipath P.; The tryptophan\u2013kynurenine pathway in immunomodulation and cancer metastasis. Cancer Med  2023,12(18),18691-18701","journal-title":"Cancer Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1568005033342145","volume":"3","author":"Veselovsky A.","year":"2003","unstructured":"Veselovsky A.; Ivanov A.; Strategy of computer-aided drug design. Curr Drug Targets Infect Disord  2003,3(1),33-40","journal-title":"Curr Drug Targets Infect Disord"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ph17010022","volume":"17","author":"Niazi S.K.","year":"2023","unstructured":"Niazi S.K.; Mariam Z.; Computer-aided drug design and drug discovery: A prospective analysis. Pharmaceuticals  2023,17(1),22","journal-title":"Pharmaceuticals"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-981-19-9786-0_9","author":"Ejiofor I.I.","year":"2023","unstructured":"Ejiofor I.I.; Ekeomodi C.C.; IlecChukwu A.U.; Ochiamu M.C.; CADD for cancer therapy: Current and future perspective. Targeted Cancer Therapy in Biomedical Engineering  2023,325-363","journal-title":"Targeted Cancer Therapy in Biomedical Engineering"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1672-0229(08)60030-3","volume":"7","author":"Guda P.","year":"2009","unstructured":"Guda P.; Chittur S.V.; Guda C.; Comparative analysis of protein-protein interactions in cancer-associated genes. Genomics Proteomics Bioinformatics  2009,7(1-2),25-36","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fphar.2019.01614","volume":"10","author":"Choudhari A.S.","year":"2020","unstructured":"Choudhari A.S.; Mandave P.C.; Deshpande M.; Ranjekar P.; Prakash O.; Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front Pharmacol  2020,10(1614),1614","journal-title":"Front Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13046-018-0700-z","volume":"37","author":"Yao S.","year":"2018","unstructured":"Yao S.; Li L.; Su X.; Wang K.; Lu Z.; Yuan C.; Feng J.; Yan S.; Kong B.; Song K.; Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: In vitro and in vivo. J Exp Clin Cancer Res  2018,37(1),29","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1201\/9781003486237-17","author":"Subramanyam V.","year":"2024","unstructured":"Subramanyam V.; Ganapathy R.; Pillai A.K.; Palol V.V.; Haema G.; Sivaprakasam M.; Biswas I.; Anthocyanins and its derivatives: Systemic approach in drug delivery. Plant Derived Bioactive Compounds in Human Health and Disease  2024,274-294","journal-title":"Plant Derived Bioactive Compounds in Human Health and Disease"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"102480","DOI":"10.1016\/j.mex.2023.102480","volume":"11","author":"Palol V.V.","year":"2023","unstructured":"Palol V.V.; Saravanan S.K.; Vuree S.; Chinnadurai R.K.; Subramanyam V.; Nanophytosome formulation of \u03b2-1,3-glucan and Euglena gracilis extract for drug delivery applications. MethodsX  2023,11,102480","journal-title":"MethodsX"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"7641","DOI":"10.1016\/j.bmcl.2012.10.010","volume":"22","author":"Bakmiwewa S.M.","year":"2012","unstructured":"Bakmiwewa S.M.; Fatokun A.A.; Tran A.; Payne R.J.; Hunt N.H.; Ball H.J.; Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2. Bioorg Med Chem Lett  2012,22(24),7641-7646","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/cells10071603","volume":"10","author":"Mor A.","year":"2021","unstructured":"Mor A.; Tankiewicz-Kwedlo A.; Krupa A.; Pawlak D.; Role of kynurenine pathway in oxidative stress during neurodegenerative disorders. Cells  2021,10(7),1603","journal-title":"Cells"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"Kanehisa M.","year":"2000","unstructured":"Kanehisa M.; Goto S.; KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res  2000,28(1),27-30","journal-title":"Nucleic Acids Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.12688\/f1000research.4410.2","volume":"3","author":"Nersisyan L.","year":"2014","unstructured":"Nersisyan L.; Samsonyan R.; Arakelyan A.; CyKEGGParser: Tailoring KEGG pathways to fit into systems biology analysis workflows. F1000 Res  2014,3,145","journal-title":"F1000 Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1093\/bioinformatics\/btp517","volume":"25","author":"Scardoni G.","year":"2009","unstructured":"Scardoni G.; Petterlini M.; Laudanna C.; Analyzing biological network parameters with CentiScaPe. Bioinformatics  2009,25(21),2857-2859","journal-title":"Bioinformatics"},{"key":"ref=23","unstructured":"UALCAN.  Available from:  https:\/\/ualcan.path.uab.edu\/"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","volume":"19","author":"Tomczak K.","year":"2015","unstructured":"Tomczak K.; Czerwi\u0144ska P.; Wiznerowicz M.; The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge. Contemp Oncol  2015,19(1A),A68-A77","journal-title":"Contemp Oncol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"Li T.","year":"2017","unstructured":"Li T.; Fan J.; Wang B.; Traugh N.; Chen Q.; Liu J.S.; Li B.; Liu X.S.; TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res  2017,77(21),e108-e110","journal-title":"Cancer Res"},{"key":"ref=26","unstructured":"TIMER 2.0.  Available from:  http:\/\/cistrome.org\/TIMER\/"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0968-0004(97)01140-7","volume":"22","author":"Laskowski R.A.","year":"1997","unstructured":"Laskowski R.A.; Hutchinson E.G.; Michie A.D.; Wallace A.C.; Jones M.L.; Thornton J.M.; PDBsum: A web-based database of summaries and analyses of all PDB structures. Trends Biochem Sci  1997,22(12),488-490","journal-title":"Trends Biochem Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/elps.1150181505","volume":"18","author":"Guex N.","year":"1997","unstructured":"Guex N.; Peitsch M.C.; SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis  1997,18(15),2714-2723","journal-title":"Electrophoresis"},{"key":"ref=29","unstructured":"IMPPAT: Indian medicinal plants, phytochemistry and therapeutics.  Available from:  https:\/\/cb.imsc.res.in\/imppat\/"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1038\/s41598-018-22631-z","volume":"8","author":"Mohanraj K.","year":"2018","unstructured":"Mohanraj K.; Karthikeyan B.S.; Vivek-Ananth R.P.; Chand R.P.B.; Aparna S.R.; Mangalapandi P.; Samal A.; IMPPAT: A curated database of Indian M edicinal P lants, P hytochemistry A nd T herapeutics. Sci Rep  2018,8(1),4329","journal-title":"Sci Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cbdv.200890031","volume":"5","author":"Abou-Donia A.H.","year":"2008","unstructured":"Abou-Donia A.H.; Toaima S.M.; Hammoda H.M.; Shawky E.; Kinoshita E.; Takayama H.; Phytochemical and biological investigation of Hymenocallis littoralis SALISB. Chem Biodivers  2008,5(2),332-340","journal-title":"Chem Biodivers"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1046\/j.1365-2745.2003.00783.x","volume":"91","author":"Thomas P.A.","year":"2003","unstructured":"Thomas P.A.; Polwart A.; Taxus baccata L. J Ecol  2003,91(3),489-524","journal-title":"J Ecol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.18520\/cs\/v109\/i10\/1790-1801","volume":"109","author":"Singh S.","year":"2015","unstructured":"Singh S.; Anantha Krishna T.H.; Kamalraj S.; Kuriakose G.C.; Valayil J.M.; Jayabaskaran C.; Phytomedicinal importance of Saraca asoca (Ashoka): An exciting past, an emerging present and a promising future. Curr Sci  2015,109(10),1790-1801","journal-title":"Curr Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1055\/s-0029-1185455","volume":"75","author":"Kongtun S.","year":"2009","unstructured":"Kongtun S.; Jiratchariyakul W.; Kummalue T.; Tan-ariya P.; Kunnachak S.; Wilhelm Frahm A.; Cytotoxic properties of root extract and fruit juice of Trichosanthes cucumerina. Planta Med  2009,75(8),839-842","journal-title":"Planta Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1211\/jpp\/61.04.0001","volume":"61","author":"Mukherjee P.K.","year":"2009","unstructured":"Mukherjee P.K.; Mukherjee D.; Maji A.K.; Rai S.; Heinrich M.; The sacred lotus (Nelumbo nucifera) - Phytochemical and therapeutic profile. J Pharm Pharmacol  2009,61(4),407-422","journal-title":"J Pharm Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.2147\/OTT.S114714","volume":"10","author":"Dockery L.E.","year":"2017","unstructured":"Dockery L.E.; Gunderson C.C.; Moore K.N.; Rucaparib: The past, present, and future of a newly approved PARP inhibitor for ovarian cancer. OncoTargets Ther  2017,10,3029-3037","journal-title":"OncoTargets Ther"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem  2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","author":"Dallakyan S","year":"2015","unstructured":"Dallakyan S; Olson A J; Small-molecule library screening by docking with PyRx. Chemical Biology  2015,243-250","journal-title":"Chemical Biology"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e14232","DOI":"10.2196\/14232","volume":"1","author":"Butt S.S.","year":"2020","unstructured":"Butt S.S.; Badshah Y.; Shabbir M.; Rafiq M.; Molecular docking using chimera and autodock vina software for nonbioinformaticians. JMIR Bioinform Biotechnol  2020,1(1),e14232","journal-title":"JMIR Bioinform Biotechnol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A","year":"2017","unstructured":"Daina A; Michielin O; Zoete V; SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep  2017,7,42717","journal-title":"Sci Rep"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"Pires D.E.V.","year":"2015","unstructured":"Pires D.E.V.; Blundell T.L.; Ascher D.B.; pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem  2015,58(9),4066-4072","journal-title":"J Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/qua.24259","volume":"113","author":"Burke K.","year":"2013","unstructured":"Burke K.; Wagner L.O.; DFT in a nutshell. Int J Quantum Chem  2013,113(2),96-101","journal-title":"Int J Quantum Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1021\/jp061633o","volume":"111","author":"Zhang G.","year":"2007","unstructured":"Zhang G.; Musgrave C.B.; Comparison of DFT methods for molecular orbital eigenvalue calculations. J Phys Chem A  2007,111(8),1554-1561","journal-title":"J Phys Chem A"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.55549\/epstem.1222658","volume":"20","author":"Aytemiz F.","year":"2022","unstructured":"Aytemiz F.; Beytur M.; Yuksek H.; Experimentical and Gaussian calculations of 3-Ethyl-4-(2-benzenesulfonyloxy)-benzylideneamino-4, 5-dihydro-1H-1, 2, 4-triazol-5-one. Eurasia Proc Sci Technol Eng Math  2022,20,103-111","journal-title":"Eurasia Proc Sci Technol Eng Math"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"020449","DOI":"10.1063\/1.4946500","volume":"1728","author":"Christy P.A.","year":"2016","unstructured":"Christy P.A.; Premkumar S.; Asath R.M.; Mathavan T.; Benial A.M.; Vibrational spectroscopic and structural investigations on fullerene: A DFT approach. AIP Conf Proc  2016,1728(1),020449","journal-title":"AIP Conf Proc"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.theochem.2007.06.002","volume":"820","author":"Guo Y.","year":"2007","unstructured":"Guo Y.; Xue Y.; De Zhu X.; Yan G.S.; Density functional theory investigations on the conformational stability and vibrational spectra of the model compound of vitamin K. J Mol Struct THEOCHEM  2007,820(1-3),40-47","journal-title":"J Mol Struct THEOCHEM"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-4939-6798-8_14","author":"Bhachoo J","year":"2017","unstructured":"Bhachoo J; Beuming T; Investigating protein\u2013peptide interactions using the Schr\u00f6dinger computational suite. Modeling Peptide-Protein Interactions  2017,235-254","journal-title":"Modeling Peptide-Protein Interactions"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1008763014207","volume":"18","author":"Massova I.","year":"2000","unstructured":"Massova I.; Kollman P.A.; Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding. Perspect Drug Discov Des  2000,18(1),113-135","journal-title":"Perspect Drug Discov Des"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","volume":"143","author":"Rich J.T.","year":"2010","unstructured":"Rich J.T.; Neely J.G.; Paniello R.C.; Voelker C.C.J.; Nussenbaum B.; Wang E.W.; A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg  2010,143(3),331-336","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/sim.4780040112","volume":"4","author":"Cuzick J.","year":"1985","unstructured":"Cuzick J.; A wilcoxon-type test for trend. Stat Med  1985,4(1),87-90","journal-title":"Stat Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2885.2004.00602.x","volume":"27","author":"Toutain P.L.","year":"2004","unstructured":"Toutain P.L.; Bousquet-M\u00e9lou A.; Volumes of distribution. J Vet Pharmacol Ther  2004,27(6),441-453","journal-title":"J Vet Pharmacol Ther"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jps.20536","volume":"95","author":"Fujita T.","year":"2006","unstructured":"Fujita T.; Urban T.J.; Leabman M.K.; Fujita K.; Giacomini K.M.; Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci  2006,95(1),25-36","journal-title":"J Pharm Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/mutage\/gead033","volume":"39","author":"Thomas D.N.","year":"2024","unstructured":"Thomas D.N.; Wills J.W.; Tracey H.; Baldwin S.J.; Burman M.; Williams A.N.; Harte D.S.G.; Buckley R.A.; Lynch A.M.; Ames test study designs for nitrosamine mutagenicity testing: Qualitative and quantitative analysis of key assay parameters. Mutagenesis  2024,39(2),78-95","journal-title":"Mutagenesis"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1124\/mol.105.014035","volume":"68","author":"Zhou J.","year":"2005","unstructured":"Zhou J.; Augelli-Szafran C.E.; Bradley J.A.; Chen X.; Koci B.J.; Volberg W.A.; Sun Z.; Cordes J.S.; Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity. Mol Pharmacol  2005,68(3),876-884","journal-title":"Mol Pharmacol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-0716-1960-5_11","author":"Pizzo F","year":"2022","unstructured":"Pizzo F; Gadaleta D; Benfenati E; In silico models for repeated-dose toxicity (RDT): Prediction of the no observed adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) for drugs. In Silico Methods for Predicting Drug Toxicity  2022,241-258","journal-title":"In Silico Methods for Predicting Drug Toxicity"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/etc.5620160514","volume":"16","author":"Russom C.L.","year":"1997","unstructured":"Russom C.L.; Bradbury S.P.; Broderius S.J.; Hammermeister D.E.; Drummond R.A.; Predicting modes of toxic action from chemical structure: Acute toxicity in the fathead minnow (Pimephales promelas). Environ Toxicol Chem  1997,16(5),948-967","journal-title":"Environ Toxicol Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"Daina A.","year":"2016","unstructured":"Daina A.; Zoete V.; A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem  2016,11(11),1117-1121","journal-title":"ChemMedChem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jclinepi.2007.04.021","volume":"61","author":"Saary M.J.","year":"2008","unstructured":"Saary M.J.; Radar plots: A useful way for presenting multivariate health care data. J Clin Epidemiol  2008,61(4),311-317","journal-title":"J Clin Epidemiol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev  2001,46(1-3),3-26","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"Ertl P.","year":"2000","unstructured":"Ertl P.; Rohde B.; Selzer P.; Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem  2000,43(20),3714-3717","journal-title":"J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/ci500467k","volume":"54","author":"Daina A.","year":"2014","unstructured":"Daina A.; Michielin O.; Zoete V.; iLOGP: A simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach. J Chem Inf Model  2014,54(12),3284-3301","journal-title":"J Chem Inf Model"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1021\/ci900301v","volume":"50","author":"Podolyan Y.","year":"2010","unstructured":"Podolyan Y.; Walters M.A.; Karypis G.; Assessing synthetic accessibility of chemical compounds using machine learning methods. J Chem Inf Model  2010,50(6),979-991","journal-title":"J Chem Inf Model"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"128715","DOI":"10.1016\/j.molstruc.2020.128715","volume":"1220","author":"Mumit M.A.","year":"2020","unstructured":"Mumit M.A.; Pal T.K.; Alam M.A.; Islam M.A.A.A.A.; Paul S.; Sheikh M.C.; DFT studies on vibrational and electronic spectra, HOMO\u2013LUMO, MEP, HOMA, NBO and molecular docking analysis of benzyl-3-N-(2,4,5-trimethoxyphenylmethylene)hydrazinecarbodithioate. J Mol Struct  2020,1220,128715","journal-title":"J Mol Struct"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1021\/acs.jpca.7b07682","volume":"121","author":"Hou G.L.","year":"2017","unstructured":"Hou G.L.; Wang X.B.; McCoy A.B.; Borden W.T.; Experimental and theoretical studies of the F  + H\u2013F transition-state region by photodetachment of [F\u2013H\u2013F] . J Phys Chem A  2017,121(41),7895-7902","journal-title":"J Phys Chem A"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1021\/acs.jcim.2c01444","volume":"63","author":"Maruyama Y.","year":"2023","unstructured":"Maruyama Y.; Igarashi R.; Ushiku Y.; Mitsutake A.; Analysis of protein folding simulation with moving root mean square deviation. J Chem Inf Model  2023,63(5),1529-1541","journal-title":"J Chem Inf Model"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/608406","volume":"2012","author":"Chew V.","year":"2012","unstructured":"Chew V.; Toh H.C.; Abastado J.P.; Immune microenvironment in tumor progression: Characteristics and challenges for therapy. J Oncol  2012,2012(1),1-10","journal-title":"J Oncol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e20342","DOI":"10.7717\/peerj.20342","volume":"13","author":"Ou Z.","year":"2025","unstructured":"Ou Z.; Xu A.; Su H.; Liu Y.; Li J.; Tryptophan-kynurenine pathway: A possible new mechanism for the prevention and treatment of reproductive system-related diseases. PeerJ  2025,13,e20342","journal-title":"PeerJ"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673450210260701040244","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/256367\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673450210260701040244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:17:17Z","timestamp":1792991837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/256367\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":67,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673450210260701040244","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}